A PhD student position is available in the University of Helsinki Cancer Gene Therapy Group (CGTG), led by Professor Akseli Hemminki, MD, PhD. CGTG is located in Haartman Institute on the Helsinki Academic Medical Campus in Meilahti, Helsinki, Finland. Our research involves cancer immunotherapy with oncolytic viruses and adaptive cell therapies such as T-cell therapy, and their interplay. Please see http://www.hi.helsinki.fi/cgtg/index.html for more information.

We offer you:

· an opportunity to work in a high quality group at the very cutting edge of cancer research, both nationally and internationally

· a chance to be involved in translational and cross-field science utilizing techniques from genetic engineering, immunology, virology, cell biology, molecular biology, clinical medicine and animal work

· a stimulating research environment on the largest biomedical research campus in Finland, with tight collaborations locally and globally

· a chance for completing a PhD and growing into an independent researcher

· financial support through a grant

What is expected of you:

· a completed or nearly completed Master’s degree or equivalent from a biological, biomedical or medical sciences field.

· high motivation level and work morale.

· previous experience in cell culture, immunology or virology is required.

· skills and training in working with model animals (rodents) is required.

· experience in laboratory work, writing manuscripts or assembling scientific data will count in your favor

· adequate written and oral skills in the English language

· possibility of interviewing at CGTG in person (not via Skype)

The start time is negotiable, but spring or early summer 2015 is preferable. Please address your queries and applications in English, with CV, to Minna Oksanen, minna.k.oksanen@helsinki.fi , tel. 02941 26832, 26.4.2015 at the latest.